Hiroaki Inomata

636 total citations
25 papers, 459 citations indexed

About

Hiroaki Inomata is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hiroaki Inomata has authored 25 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hiroaki Inomata's work include Thyroid Disorders and Treatments (19 papers), Growth Hormone and Insulin-like Growth Factors (8 papers) and Congenital heart defects research (4 papers). Hiroaki Inomata is often cited by papers focused on Thyroid Disorders and Treatments (19 papers), Growth Hormone and Insulin-like Growth Factors (8 papers) and Congenital heart defects research (4 papers). Hiroaki Inomata collaborates with scholars based in Japan, United Kingdom and United States. Hiroaki Inomata's co-authors include Nozomu Sasaki, Hirokazu Sato, Shigetaka Sugihara, Hisashi Ohnishi, Hiroo Niimi, Mikiya Fujieda, Shohei Harada, Hirokazu Sato, Shigeki Miyamoto and Yan‐Hong Gu and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The Journal of Pediatrics and IEEE Transactions on Electron Devices.

In The Last Decade

Hiroaki Inomata

25 papers receiving 441 citations

Peers

Hiroaki Inomata
Edward A. Benson United States
Young‐Lim Shin South Korea
Dorothy Ellingsen United States
Rajesh Khadgawat India
JF Martin United States
Murray Robertson Canada
Chiaw Ling Chng Singapore
Anna Madetko‐Talowska Poland
Aart‐Jan van der Lelij Netherlands
V. Klauss Germany
Edward A. Benson United States
Hiroaki Inomata
Citations per year, relative to Hiroaki Inomata Hiroaki Inomata (= 1×) peers Edward A. Benson

Countries citing papers authored by Hiroaki Inomata

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Inomata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Inomata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Inomata more than expected).

Fields of papers citing papers by Hiroaki Inomata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Inomata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Inomata. The network helps show where Hiroaki Inomata may publish in the future.

Co-authorship network of co-authors of Hiroaki Inomata

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Inomata. A scholar is included among the top collaborators of Hiroaki Inomata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Inomata. Hiroaki Inomata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sato, Hirokazu, Kanshi Minamitani, Masanori Minagawa, et al.. (2014). Clinical features at diagnosis and responses to antithyroid drugs in younger children with Graves’ disease compared with adolescent patients. Journal of Pediatric Endocrinology and Metabolism. 27(7-8). 677–83. 6 indexed citations
2.
Sato, Hirokazu, Nozomu Sasaki, Kanshi Minamitani, et al.. (2012). Higher dose of methimazole causes frequent adverse effects in the management of Graves’ disease in children and adolescents. Journal of Pediatric Endocrinology and Metabolism. 25(9-10). 863–7. 14 indexed citations
3.
Minamitani, Kanshi & Hiroaki Inomata. (2012). Neonatal screening for congenital hypothyroidism in Japan.. PubMed. 10 Suppl 1. 79–88. 10 indexed citations
4.
Sato, Hirokazu, Masanori Minagawa, Nozomu Sasaki, et al.. (2011). Comparison of methimazole and propylthiouracil in the management of children and adolescents with Graves’ disease: efficacy and adverse reactions during initial treatment and long-term outcome. Journal of Pediatric Endocrinology and Metabolism. 24(5-6). 257–63. 28 indexed citations
5.
Minamitani, Kanshi, et al.. (2011). A Report of Three Girls with Antithyroid Drug-Induced Agranulocytosis; Retrospective Analysis of 18 Cases Aged 15 Years or Younger Reported between 1995 and 2009. Clinical Pediatric Endocrinology. 20(2). 39–46. 11 indexed citations
6.
Gu, Yan‐Hong, et al.. (2010). Time Trend and Geographic Distribution of Treated Patients with Congenital Hypothyroidism Relative to the Number of Available Endocrinologists in Japan. The Journal of Pediatrics. 157(1). 153–157. 10 indexed citations
7.
8.
9.
Jibiki, Toshiaki, Masaru Terai, Takafumi Honda, et al.. (2004). Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki disease. European Journal of Pediatrics. 163(4-5). 229–233. 43 indexed citations
10.
Ohnishi, Hisashi, et al.. (2003). Color Doppler Ultrasonography: Diagnosis of Ectopic Thyroid Gland in Patients with Congenital Hypothyroidism Caused by Thyroid Dysgenesis. The Journal of Clinical Endocrinology & Metabolism. 88(11). 5145–5149. 56 indexed citations
11.
Ogawa, Eishin, Kenji Fujieda, Katsuhiko Tachibana, et al.. (2003). Mortality in Patients with Congenital 21-Hydroxylase Deficiency Diagnosed after the Introduction of a Newborn Screening Program in Japan. Clinical Pediatric Endocrinology. 12(1). 19–23. 3 indexed citations
12.
Ohnishi, Hisashi, Hiroaki Inomata, Tomoyuki Watanabe, et al.. (2002). Clinical Utility of Thyroid Ultrasonography in the Diagnosis of Congenital Hypothyroidism.. Endocrine Journal. 49(3). 293–297. 25 indexed citations
13.
Inomata, Hiroaki, Nobuo Matsuura, Katsuhiko Tachibana, et al.. (1999). Guideline for Neonatal Mass-screening for Congenital Hypothyroidism. Clinical Pediatric Endocrinology. 8(1). 51–55. 13 indexed citations
14.
Kosugi, Shinji, Yuichi Sato, Akira Matsuda, et al.. (1998). High Prevalence of T354P Sodium/Iodide Symporter Gene Mutation in Japanese Patients with Iodide Transport Defect Who Have Heterogeneous Clinical Pictures1. The Journal of Clinical Endocrinology & Metabolism. 83(11). 4123–4129. 52 indexed citations
15.
Sato, Hirokazu, Hiroaki Inomata, Nozomu Sasaki, Hiroo Niimi, & Hironori Nakajima. (1988). Optimum Replacement Dose of Thyroid Hormone Assesed by Highly Sensitive TSH Determination in Patients with Congenital Hypothyroidism.. Endocrinologia Japonica. 35(4). 531–536. 5 indexed citations
16.
17.
Sato, Hirokazu, Hiroaki Inomata, Nozomu Sasaki, Hiroo Niimi, & Hironori Nakajima. (1987). Monitoring Treatment of Congenital Hypothyroidism by Highly Sensitive Immunoradiometric Assay for Thyroid Stimulating Hormone.. Endocrinologia Japonica. 34(4). 569–575. 5 indexed citations
18.
Sato, Hirokazu, Hiroaki Inomata, Nozomu Sasaki, Hiroo Niimi, & Hironori Nakajima. (1987). Recovery Period of Hypersecretion of Thyroid‐Stimulating Hormone in Patients with Congenital Hypothyroidism Treated with Thyroid Hormone. Pediatrics International. 29(6). 833–836. 3 indexed citations
19.
Inomata, Hiroaki, et al.. (1986). Submicrometer insulated-gate inverted-structure HEMT for high-speed large-logic-swing DCFL gate. IEEE Transactions on Electron Devices. 33(5). 608–615. 15 indexed citations
20.
Niimi, Hiroo, Nozomu Sasaki, Hiroaki Inomata, & Hironori Nakajima. (1980). Evaluation of L-thyroxine requirement in treatment of congenital hypothyroidism.. Endocrinologia Japonica. 27(6). 733–738. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward A. Benson Breakdown of academic impact, for papers by Young‐Lim Shin Breakdown of academic impact, for papers by Dorothy Ellingsen Breakdown of academic impact, for papers by Rajesh Khadgawat Breakdown of academic impact, for papers by JF Martin Breakdown of academic impact, for papers by Murray Robertson Breakdown of academic impact, for papers by Chiaw Ling Chng Breakdown of academic impact, for papers by Anna Madetko‐Talowska Breakdown of academic impact, for papers by Aart‐Jan van der Lelij Breakdown of academic impact, for papers by V. Klauss
Rankless by CCL
2026